News
Supriya Lifescience standalone net profit declines 42.00% in the September 2026 quarter
07-Nov-2026 | 12:39
Sales rise 3.24% to Rs 206.30 crore
Net profit of Supriya Lifescience declined 42.00% to Rs 29.25 crore in the quarter ended September 2026 as against Rs 50.43 crore during the previous quarter ended September 2025. Sales rose 3.24% to Rs 206.30 crore in the quarter ended September 2026 as against Rs 199.83 crore during the previous quarter ended September 2025.
| Particulars | Quarter Ended | ||
| Sep. 2026 | Sep. 2025 | % Var. | |
| Sales | 206.30 | 199.83 | 3 |
| OPM % | 22.01 | 36.36 | - |
| PBDT | 47.24 | 74.96 | -37 |
| PBT | 37.78 | 68.32 | -45 |
| NP | 29.25 | 50.43 | -42 |
Powered by Capital Market - Live News